anmelden
OMX Nordic 40
2.685,57
PKT
-21,68
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.04.23 | Volvo (B) Buy | Deutsche Bank AG | |
| 21.04.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 20.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 20.04.23 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 20.04.23 | Nokia Overweight | JP Morgan Chase & Co. | |
| 19.04.23 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
| 19.04.23 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 18.04.23 | Volvo (B) Sell | UBS AG | |
| 18.04.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 18.04.23 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 18.04.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 17.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 17.04.23 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 15.04.23 | Nokia Overweight | JP Morgan Chase & Co. | |
| 14.04.23 | Novo Nordisk Sell | UBS AG | |
| 14.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 13.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 13.04.23 | Volvo (B) Buy | Deutsche Bank AG | |
| 13.04.23 | Novo Nordisk Outperform | Credit Suisse Group | |
| 12.04.23 | AstraZeneca Overweight | Barclays Capital | |
| 12.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 12.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 12.04.23 | Volvo (B) Sell | UBS AG | |
| 12.04.23 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 12.04.23 | Volvo (B) Hold | Jefferies & Company Inc. | |
| 11.04.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 11.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.04.23 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 06.04.23 | Kone Equal Weight | Barclays Capital | |
| 05.04.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
| 04.04.23 | Volvo (B) Buy | Deutsche Bank AG |
